The IDIAP Jordi Gol
Who we are
Organization
Quality Certification
Strategic plan
Annual reports
HRS4R
Transparency
Research
Territorial Support Units (USR)
Research Areas
Publications
Projects
CEIm
CEIM presentation
How to Submit the Documentation to the CEIM
Rates of The CEI
CEI meeting calendar
Regulations and links of interest CEI
Services and Platforms
AGICAP
Grants to Finance Research
Clinical Trial Monitoring
Platforms Questionnaires
Sidiap Database
Real World Lab
Tools-Help
Scientific Tools
Management Tools
IDIAP Management Tools
Innovation
News
Link GIR
Acces GIR
Login
Català
Castellano
English
The IDIAP Jordi Gol
Who we are
Organization
Quality Certification
Strategic plan
Annual reports
HRS4R
Transparency
Research
Territorial Support Units (USR)
Research Areas
Publications
Projects
CEIm
CEIM presentation
How to Submit the Documentation to the CEIM
Rates of The CEI
CEI meeting calendar
Regulations and links of interest CEI
Services and Platforms
AGICAP
Grants to Finance Research
Clinical Trial Monitoring
Platforms Questionnaires
Sidiap Database
Real World Lab
Tools-Help
Scientific Tools
Management Tools
IDIAP Management Tools
Innovation
News
Link GIR
Search
Most popular
COL·LABORA
Menu
English
Català
Español
Home
Àrees Recerca
HEALTH SERVICES RESEARCH
EMAP
EMAP
Estudis en Medicaments en Atenció Primària (EMAP)
Group leader
Rosa Morros Pedrós
rmorros@idiapjgol.org
Presentation
Team
Publications
Projects
News
Presentation
Team
Publications
Projects
News
Projects
Group projects
Retrospective Longitudinal Study on Edoxaban in Patients with Non-Valvular Atrial Fibrillation in Europe
Principal investigators:
Rosa Morros Pedrós, Maria Giner Soriano
Code:
4R21/145
Start year:
2021
Funders:
Syneos Health Consulting INC.
Post-authorisation Safety Study of Rimegepant in Patients with Migraine and History of Cardiovascular Disease in European Countries
Principal investigators:
Maria Giner Soriano
Code:
4R22/026
Start year:
2022
Funders:
Research Triangle Institute (RTI)
Uso de fármacos en mujeres embarazadas y lactantes. Consecuencias en la salud de estas mujeres y en la de su descendencia.
Principal investigators:
Cristina Vedia Urgell
Code:
4R22/042
Start year:
2022
Funders:
Generalitat Catalunya
Quality, efficacy and safety studies on medicines, Lot 5 Pharmacoepidemiological research (V. HEBRON)
Principal investigators:
Rosa Morros Pedrós, Maria Giner Soriano
Code:
9F21/006
Start year:
2021
Funders:
European Medicines Agency (EMA)
Utilització de fàrmacs Insuficiència Cardíaca
Principal investigators:
Maria Giner Soriano
Code:
4R22/211
Start year:
2022
Funders:
Institut d’Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol)
Anterior
1
…
4
5
6
7
8
…
11
Següent
Board of Trustees
Collaborators
Accreditations